11-61392638-C-A

Variant summary

Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4

The NM_001173990.3(TMEM216):​c.7C>A​(p.Pro3Thr) variant causes a missense change. The variant allele was found at a frequency of 0.00000651 in 1,382,034 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P3S) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000065 ( 0 hom. )

Consequence

TMEM216
NM_001173990.3 missense

Scores

3
8
8

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:4

Conservation

PhyloP100: 4.24

Publications

0 publications found
Variant links:
Genes affected
TMEM216 (HGNC:25018): (transmembrane protein 216) This locus encodes a transmembrane domain-containing protein. Mutations at this locus have been associated with Meckel-Gruber Syndrome Type 2, and Joubert Syndrome 2, also known as Cerebello-oculorenal Syndrome 2. [provided by RefSeq, Aug 2010]
TMEM216 Gene-Disease associations (from GenCC):
  • Joubert syndrome 2
    Inheritance: AR Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • Joubert syndrome with oculorenal defect
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Meckel syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • orofaciodigital syndrome type 6
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.4115949).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TMEM216NM_001173990.3 linkc.7C>A p.Pro3Thr missense_variant Exon 1 of 5 ENST00000515837.7 NP_001167461.1 Q9P0N5-1
TMEM216NM_001173991.3 linkc.7C>A p.Pro3Thr missense_variant Exon 1 of 5 NP_001167462.1 Q9P0N5-3
TMEM216NM_016499.6 linkc.-191C>A 5_prime_UTR_variant Exon 1 of 5 NP_057583.2 Q9P0N5-2
TMEM216NM_001330285.2 linkc.-191C>A 5_prime_UTR_variant Exon 1 of 5 NP_001317214.1 Q9P0N5J3QT25

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TMEM216ENST00000515837.7 linkc.7C>A p.Pro3Thr missense_variant Exon 1 of 5 2 NM_001173990.3 ENSP00000440638.1 Q9P0N5-1
TMEM216ENST00000334888.10 linkc.7C>A p.Pro3Thr missense_variant Exon 1 of 5 2 ENSP00000334844.5 Q9P0N5-3

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.00000651
AC:
9
AN:
1382034
Hom.:
0
Cov.:
32
AF XY:
0.0000117
AC XY:
8
AN XY:
682044
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31542
American (AMR)
AF:
0.00
AC:
0
AN:
35654
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25106
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35604
South Asian (SAS)
AF:
0.0000757
AC:
6
AN:
79212
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
33468
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5656
European-Non Finnish (NFE)
AF:
0.00000278
AC:
3
AN:
1078020
Other (OTH)
AF:
0.00
AC:
0
AN:
57772
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.531
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Joubert syndrome Uncertain:1
Jun 27, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces proline, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 3 of the TMEM216 protein (p.Pro3Thr). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with TMEM216-related conditions. ClinVar contains an entry for this variant (Variation ID: 452672). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Joubert syndrome 2;C1864148:Meckel syndrome, type 2 Uncertain:1
May 18, 2024
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Uncertain:1
Oct 12, 2017
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

A variant of uncertain significance has been identified in the TMEM216 gene. The P3T variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The P3T variant is not observed in large population cohorts (Lek et al., 2016). The P3T variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species; and in silico analysis predicts this variant is probably damaging to the protein structure/function. Based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. -

Joubert syndrome 2 Uncertain:1
Sep 16, 2020
Natera, Inc.
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.095
BayesDel_addAF
Pathogenic
0.22
D
BayesDel_noAF
Uncertain
0.080
CADD
Benign
22
DANN
Uncertain
1.0
DEOGEN2
Benign
0.015
T;.
Eigen
Benign
0.15
Eigen_PC
Uncertain
0.27
FATHMM_MKL
Uncertain
0.83
D
LIST_S2
Benign
0.32
T;T
M_CAP
Uncertain
0.25
D
MetaRNN
Benign
0.41
T;T
MetaSVM
Uncertain
-0.14
T
MutationAssessor
Benign
0.55
N;N
PhyloP100
4.2
PrimateAI
Uncertain
0.58
T
PROVEAN
Benign
-1.6
N;N
REVEL
Uncertain
0.40
Sift
Pathogenic
0.0
D;D
Sift4G
Pathogenic
0.0
D;D
Vest4
0.48
MutPred
0.16
Gain of helix (P = 0.0496);Gain of helix (P = 0.0496);
MVP
0.57
MPC
0.61
ClinPred
0.91
D
GERP RS
5.6
PromoterAI
0.18
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.6
Varity_R
0.41
gMVP
0.55
Mutation Taster
=89/11
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1554972409; hg19: chr11-61160110; API